AFMD
Affimed NV
NASDAQ · Healthcare · Biotechnology · DE
$0.18
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.15x
- Price / sales
- 2.97x
- Price / cash flow
- -0.03x
Enterprise value
- Enterprise value
- -$10.6M
- EV / sales
- -10.77x
- EV / EBITDA
- 0.14x
- EV / EBIT
- 0.13x
- Market cap
- $2.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2024